StockDuty ← Dashboard Oct 30, 2026 03:50 PM ET
SignalFDA/Bio

$300k for a personalized cancer vaccine

High-priority alert based on source significance and keyword relevance.

What happened: The RNA Foundry, a project of PopVax in Hyderabad, India, is offering contract research, development, and manufacturing services for personalized cancer vaccines, and expects most projects to cost around $300,000 and take 8-10 weeks. Key numbers: About $300,000 per project; 8-10 weeks per Why it matters: The company says it started the service after numerous requests and cites Merck and Moderna's melanoma results and BioNTech and Genentech's pancreatic cancer data as signs RNA vaccines may become part of cancer care, while approvals may come too late for some patients.
The RNA Foundry, a project of PopVax in Hyderabad, India, is offering contract research, development, and manufacturing services for personalized cancer vaccines, and expects most projects to cost around $300,000 and take 8-10 weeks.
The company says it started the service after numerous requests and cites Merck and Moderna's melanoma results and BioNTech and Genentech's pancreatic cancer data as signs RNA vaccines may become part of cancer care, while approvals may come too late for some patients.
Sources